<bill session="116" type="s" number="946" updated="2022-11-01T18:47:28Z">
  <state datetime="2019-03-28">REFERRED</state>
  <status>
    <introduced datetime="2019-03-28"/>
  </status>
  <introduced datetime="2019-03-28"/>
  <titles>
    <title type="display">Henrietta Lacks Enhancing Cancer Research Act of 2019</title>
    <title type="short" as="introduced">Henrietta Lacks Enhancing Cancer Research Act of 2019</title>
    <title type="official" as="introduced">A bill to direct the Comptroller General of the United States to complete a study on barriers to participation in federally funded cancer clinical trials by populations that have been traditionally underrepresented in such trials.</title>
  </titles>
  <sponsor bioguide_id="V000128"/>
  <cosponsors>
    <cosponsor bioguide_id="C000141" joined="2019-03-28"/>
    <cosponsor bioguide_id="C001035" joined="2020-09-17"/>
    <cosponsor bioguide_id="G000555" joined="2020-09-23"/>
    <cosponsor bioguide_id="J000300" joined="2020-09-17"/>
    <cosponsor bioguide_id="S001203" joined="2020-10-22"/>
    <cosponsor bioguide_id="T000464" joined="2020-09-23"/>
    <cosponsor bioguide_id="W000802" joined="2020-09-17"/>
  </cosponsors>
  <actions>
    <action datetime="2019-03-28">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2019-03-28" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSHR" name="Senate Health, Education, Labor, and Pensions" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="116" type="h" number="1966" relation="identical"/>
    <bill session="116" type="h" number="6637" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Cancer"/>
    <term name="Congressional oversight"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Government studies and investigations"/>
    <term name="Medical research"/>
    <term name="Minority health"/>
    <term name="Public participation and lobbying"/>
  </subjects>
  <amendments/>
  <summary date="2020-12-18T17:21:54Z" status="Introduced in Senate">Henrietta Lacks Enhancing Cancer Research Act of 2019

This bill requires the Government Accountability Office to complete a study reviewing how federal agencies address barriers to participation in federally-funded cancer clinical trials by individuals from underrepresented populations and provide recommendations for addressing such barriers.</summary>
</bill>
